QDEL Stock Summary and Trading Ideas (Quidelortho | NASDAQ:QDEL)

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

Quidelortho trades on the NASDAQ stock market under the symbol QDEL.

As of November 5, 2026, QDEL stock price declined to $13.74 with 37,454 million shares trading.

QDEL has a beta of 0.85, meaning it tends to be less sensitive to market movements. QDEL has a correlation of 0.01 to the broad based SPY ETF.

QDEL has a market cap of $935.44 million. This is considered a Small Cap stock.

Last quarter Quidelortho reported $619 million in Revenue and $.31 earnings per share. This fell short of revenue expectation by $-6 million and exceeded earnings estimates by $.13.

In the last 3 years, QDEL traded as high as $75.86 and as low as $9.92.

The top ETF exchange traded funds that QDEL belongs to (by Net Assets): IJR, AVUV, IWM, VTI, VB.

QDEL has underperformed the market in the last year with a price return of -49.4% while the SPY ETF gained +13.5%. QDEL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -21.8% and -2.4%, respectively, while the SPY returned -1.4% and -1.8%, respectively.

QDEL support price is $13.55 and resistance is $15.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QDEL shares will trade within this expected range on the day.